• Nurr1-Positive Neuron Development in the Rat Claustrum

  2026-08-20

  Fang, Wang, and Naumann mapped the developmental emergence and birthdating of Nurr1-positive neurons across the rat claustrum and adjacent lateral cortex. By combining embryonic 5-EdU labeling with Nurr1 in situ hybridization, the study resolved sequential neurogenesis and spatial gradients that help clarify claustrum organization.

• Cy5 Goat Anti-Rabbit IgG for MAVS Assays

  2026-08-20

  Learn how the Cy5 Goat Anti-Rabbit IgG (H+L) Antibody can support spatial and quantitative analysis of MAVS-centered antiviral signaling. This guide connects the ASB3–MAVS mechanism with practical secondary-antibody selection, controls, imaging, and storage decisions.

• 5-Methyl-CTP: From RNA Chemistry to Translation

  2026-08-19

  A translational framework for using 5-Methyl-CTP to evaluate RNA stability, translation, and delivery as connected design variables in mRNA drug development.

• N2-Alkyl-dG Lesions and R-Loop Accumulation

  2026-08-19

  The 2024 Nucleic Acids Research study shows that minor-groove N2-alkyl-dG lesions promote R-loop accumulation in chromatin and plasmid DNA, linking alkylation damage to transcriptional and genome instability. Fluorescence imaging, R-loop sequencing, transcriptional analyses, and DDX23 perturbation support a mechanistic model with implications for lesion repair and R-loop homeostasis.

• From Nutrient Stress to S-Phase: Translational Strategy

  2026-08-18

  A mechanistic and translational framework for using EdU flow cytometry to connect serine/glycine restriction, tumor-cell proliferation, immune activity, and PD-L1 lactylation in colorectal cancer research.

• Diuron as a Mechanistic Toxicology Probe

  2026-08-18

  Diuron is more than a photosynthesis inhibitor: it is a useful probe for connecting herbicide mechanism of action with environmental toxicology. This article translates recent renal-injury evidence into practical decisions for chemical handling, assay design, and interpretation.

• Cy5 Hydrazide: From Carbonyls to Translation

  2026-08-17

  A translational framework for using Cy5 hydrazide to connect oxidative-stress biology, carbonyl biomarker measurement, and nanoparticle development, with practical guidance on controls, formulation, imaging, and evidence boundaries.

• Cationic Lipoplexes for mRNA Transfection

  2026-08-17

  This study identifies modified ethanol injection as an efficient route for preparing TC-1-12-based mRNA lipoplexes, outperforming thin-film hydration for reporter expression and cellular uptake in several tumor cell models. Its findings clarify how preparation method and charge ratio influence transfection performance, while also highlighting cytotoxicity and cell-type dependence as important constraints.

• EdU Flow Cytometry Assay Kits (Cy3): S-Phase Detection

  2026-08-16

  EdU Flow Cytometry Assay Kits (Cy3) quantify DNA synthesis by labeling EdU incorporated during S phase and detecting it with a Cy3 azide through CuAAC click chemistry. The K1077 workflow avoids DNA denaturation, supports flow cytometric cell cycle analysis, and requires controls because EdU signal measures DNA synthesis rather than completed cell division.

• EV-Transferred ACLY Reprograms TAMs in HCC

  2026-08-15

  This Advanced Science study identifies extracellular vesicle-transferred ATP-citrate lyase (ACLY) as a metabolic signal that drives monocyte differentiation into immunosuppressive tumor-associated macrophages in hepatocellular carcinoma. Its CD81-targeted liposomal strategy links selective cargo delivery to palmitate production, immune-checkpoint stabilization, tumor progression, and improved anti-PD-1/PD-L1 responses.

• Hexamethonium Bromide in Autonomic Research

  2026-08-14

  Hexamethonium Bromide is a selective antagonist of neuronal-type nicotinic AChR used to separate ganglionic transmission from downstream cardiovascular effects. This article presents a causal, telemetry-centered framework for neuronal signaling pathway research and sex-aware autonomic nervous system studies.

• ASB3 Targets MAVS to Suppress Antiviral Immunity

  2026-08-14

  The 2024 reference study identifies ASB3 as an E3 ubiquitin ligase that weakens antiviral innate immunity by promoting K48-linked ubiquitination and proteasomal degradation of MAVS. Its gain- and loss-of-function, mechanistic, and animal infection experiments position ASB3 as a previously unrecognized checkpoint in RIG-I-like receptor signaling and provide a framework for studying MAVS-dependent interferon responses.

• PLGA Nano-Adjuvant Enhances Mucosal Immunity in Chicks

  2026-08-13

  The reference study developed PEI-LSP-RA-PLGA, a layered PLGA nanoparticle adjuvant designed to combine sustained delivery, intestinal targeting, and immunoregulatory activity for an inactivated H9N2 vaccine. In chicks, the formulation enhanced serum IgG, intestinal IgA, immune-organ responses, and intestinal targeting, while pathway analyses implicated CCR9/CCR6 chemokine signaling and mucosal immune networks.

• N3-kethoxal for RNA and ssDNA Accessibility

  2026-08-13

  N3-kethoxal converts exposed guanine bases into clickable structural landmarks for RNA folding, accessible-DNA mapping, and interaction studies. Its most useful advantage is workflow flexibility: the same membrane-permeable probe can support purified assays and cellular experiments, while the NET–thrombin study shows how structural probing can sharpen questions about biologically active ssDNA.

• mCherry mRNA Workflows for Kidney-Targeted Nanoparticles

  2026-08-12

  Use EZ Cap™ mCherry mRNA as a quantitative reporter for nanoparticle loading, cellular uptake, and translated protein expression. This workflow connects Cap 1 chemistry and modified nucleotides with practical excipient screening, particle-quality checks, and troubleshooting for kidney-targeted mesoscale platforms.

16276 records 1/1086 page Next 12345 下5页 Last page